The 2026 agenda is currently being developed, with publication targeted for December 2025.

In the meantime, you may review the 2025 agenda below.

Please note that changes to the agenda may occur.

08:00    Registration, partnering meetings and networking in the exhibition hall


08:40   
Welcome and introduction
Moderator: Johan RockbergProfessor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology
Samuel Lagercrantz,
Editor-in-chief, Life Science Sweden


08:50    Promoting innovation as a leader: Strategies for implementing research and innovation in the healthcare sector
Ann-Marie Wennberg Larkö, Professor in Dermatology and Venereology, Sahlgrenska Academy – Chair of the Board, Forska!Sverige


09:15    Turning the tide of antimicrobial resistance (AMR)
Fredrik Almqvist, Co-founder and CSO, QureTech Bio


09:40    Coffee, partnering meetings and networking in the exhibition hall


10:15    A Hydrogel-based wound dressing for combating antibiotic-resistant infections
Martin Andersson, Professor of Surface Chemistry, Chalmers University of Technology


10:40   
The importance of gentle liquid flow – Fluid handling perfected by gravity
Robin Öz, CEO, Ventri Labs


11:05     Exploring novel strategies to target cancer-specific features
Xiaonan Zhang, Docent in Medical Molecular Biology, Uppsala University 


11:30     Lunch, partnering meetings and networking in the exhibition hall


13:00     
From Medeon to the World – Transforming the life and future of diabetics
Adam Bruce, CEO and Chairman, Abarceo Pharma


13:25     Developing drugs for kidney disease – it takes re(n)al intelligence

Julie Williams, Chief Scientist, Renal Disease, AstraZeneca  


13:50
     Coffee, partnering meetings and networking in the exhibition hall


14:20     Current financial climate for the Swedish life science sector

Filip Einarsson, Equity Analyst – Life Science, RedEye


14:45     Exosomes – the future of modern biological medicines | Exocure – a Gothenburg-based exosome platform company
Jan Lötvall, Professor of Clinical Allergy, University of Gothenburg – Founder, Exocure
Søren MelsingCEO, Exocure


15:10     Leveraging Atlas Antibodies from the Human Protein Atlas for insights into precision medicine in cancer
Eugenia Kuteeva, Principal Scientist Antibody Development, Atlas Antibodies

 

15:35     Biomarkers you have never seen before!
Mikael Kubista, Professor, Precision BioAnalytics – Gothenburg University

 

16:00     Concluding remarks
Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology


Approx. 16:05   
End of programme

Denna webbplats använder cookies för att säkerställa att du får den bästa upplevelsen på vår webbplats. Genom att använda vår webbplats accepterar du cookies. Läs mer